Legal status by country
Is BIO101 legal?
Written by Aaron CuhaReviewed Sep 2026
How BIO101 is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Investigational, not approved | Investigational, not licensed | Investigational, not registered | Investigational, not approved |
| Note | Investigational for sarcopenia. No drug is approved for sarcopenia in any jurisdiction, which is the reason this programme matters. | None recorded | None recorded | None recorded |
US FDA status: Investigational. Not approved for any indication. No pharmaceutical treatment for sarcopenia exists anywhere.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.